RxDoctor Payments Data

Rosemary Savage, DO

Family Medicine · Ormond Beach, FLNPI 1790225134

Payments from drug & device makers

$2,153in general payments, 2019–2025

Across 114 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$303
  • AbbVie$271
  • Novo Nordisk$227
  • GSK$178
  • Daiichi Sankyo Inc.$178
  • Pfizer$108
  • plus $888 from 19 others

What the payments were for

  • Food & beverage$2,153100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,153 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$77,675
Medicare patients
309
Services billed
1,547

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban60$75,632
Trelegy ElliptaFluticasone/Umeclidin/Vilanter55$60,086
OzempicSemaglutide26$37,146
JardianceEmpagliflozin26$34,338
MounjaroTirzepatide19$21,713
Breztri AerosphereBudesonide/Glycopyr/Formoterol29$19,790
JanuviaSitagliptin Phosphate11$13,847
XareltoRivaroxaban13$13,165
Breo ElliptaFluticasone/Vilanterol14$8,738
Lantus SolostarInsulin Glargine,hum.Rec.Anlog41$6,846
Albuterol Sulfate HfaAlbuterol Sulfate137$4,519
Fluticasone-SalmeterolFluticasone Propion/Salmeterol21$3,485
Fenofibrate38$3,211
Gabapentin135$2,807
Levothyroxine Sodium339$2,467

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$108$75,63260 claims
GSKTrelegy Ellipta, Breo Ellipta$178$68,82469 claims
Novo NordiskOzempic$227$37,14626 claims
Boehringer IngelheimJardiance$19$34,33826 claims
Lilly USA, LLCMounjaro$303$21,71319 claims
AstraZenecaBreztri Aerosphere$54$19,79029 claims
MerckJanuvia$70$13,84711 claims
Johnson & JohnsonXarelto$50$13,16513 claims
AbbVieSynthroid$271$1,79115 claims
Sanofi-aventis U.S. LLCLantus$92$1,67114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Ormond Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →